Natascha Van Pelt

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Aqueous Solution

Structure Activity Relationship

Trypanosoma Cruzi

Top Venues

Archiv der Pharmazie

Science translational medicine

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Murat Bozdag, Freke Mertens, An Matheeussen, Natascha Van Pelt, Kenn Foubert, Nina Hermans, Guido R Y De Meyer, Koen Augustyns, Wim Martinet, Guy Caljon, Pieter Van der Veken
Design and Synthesis of 1,3-Diarylpyrazoles and Investigation of Their Cytotoxicity and Antiparasitic Profile. International journal of molecular sciences 25 (9) (2024)
Carla B Hartman, Phelelisiwe S Dube, Lesetja J Legoabe, Natascha Van Pelt, An Matheeussen, Guy Caljon, Richard M Beteck
Novel quinoline derivatives with broad-spectrum antiprotozoal activities. Archiv der Pharmazie 357 (6) (2024)
Federica Carnamucio, Claudia Foti, Nicola Micale, Natascha Van Pelt, An Matheeussen, Guy Caljon, Ottavia Giuffrè
Metronidazole Interaction with Cu 2+ and Zn 2+ : Speciation Study in Aqueous Solution and Biological Activity Evaluation. ACS omega 9 (26) (2024)
Federica Carnamucio, Claudia Foti, Nicola Micale, Natascha Van Pelt, An Matheeussen, Guy Caljon, Ottavia Giuffrè
Metronidazole Interaction with Cu 2+ and Zn 2+ : Speciation Study in Aqueous Solution and Biological Activity Evaluation. ACS omega 9 (26) (2024)
Carla B Hartman, Phelelisiwe S Dube, Lesetja J Legoabe, Natascha Van Pelt, An Matheeussen, Guy Caljon, Richard M Beteck
Novel quinoline derivatives with broad-spectrum antiprotozoal activities. Archiv der Pharmazie (2024)
Stéphanie Braillard, Martine Keenan, Karen J Breese, Jacob Heppell, Michael Abbott, Rafiqul Islam, David M Shackleford, Kasiram Katneni, Elly Crighton, Gong Chen, Rahul Patil, Given Lee, Karen L White, Sandra Carvalho, Richard J Wall, Giulia Chemi, Fabio Zuccotto, Silvia González, Maria Marco, Julianna Deakyne, David Standing, Gino Brunori, Jonathan J Lyon, Pablo Castañeda Casado, Isabel Camino, María Santos Martínez, Bilal Zulfiqar, Vicky Marie Avery, Pim-Bart Feijens, Natascha Van Pelt, An Matheeussen, Sarah Hendrickx, Louis Maes, Guy Caljon, Vanessa Yardley, Susan Wyllie, Susan A Charman, Eric Chatelain
DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc 1 . Science translational medicine 15 (726) (2023)